Shree Ganesh Elastoplast Q1 Profit Reaches ₹0.99 Crore

Shree Ganesh Elastoplast Limited reported a net profit of ₹0.99 crore in Q1 FY27, compared with ₹0.10 crore a year earlier, as total income rose to ₹4.09 crore from ₹0.27 crore. The result marked a return to stronger quarterly profitability ahead of the board meeting scheduled for November 5, 2026, to consider Q2 FY27 results.

What did Shree Ganesh Elastoplast report for Q1 FY27?

Shree Ganesh Elastoplast reported total income of ₹4.09 crore for the quarter ended June 30, 2026, compared with ₹2.53 crore in the preceding March quarter and ₹0.27 crore in the June 2025 quarter. Revenue from operations was reported at ₹4.07 crore, while the company disclosed profit after tax of ₹0.99 crore.

The company earned basic earnings per share of ₹1.80 in Q1 FY27, against ₹0.17 in Q1 FY26. Its EBIT was ₹0.99 crore, compared with ₹0.04 crore in Q4 FY26 and ₹0.10 crore in Q1 FY26. The reported PAT growth rate was 2,237.83% year on year, reflecting the low base in the comparable period.

How did income, expenses and margins change during the quarter?

Income increased faster than expenses during Q1 FY27. Total expenses were ₹3.10 crore, up from ₹2.49 crore in Q4 FY26 and ₹0.17 crore in Q1 FY26. The rise in expenditure followed the substantial increase in the company’s income during the quarter.

EBIT margin improved to 24.28% from 1.75% in the preceding quarter, while net profit margin reached 24.19% from 1.67%. However, the reported net margin was below the 35.14% recorded in Q1 FY26. The available earnings summary attributes this year-on-year margin decline to higher expenses, despite the increase in revenue and profit.

What is the background to Shree Ganesh Elastoplast's recovery?

Shree Ganesh Elastoplast invests in capital market and securities in India. Its quarterly financial performance has been volatile over the past several quarters. Sales were ₹8.71 crore in June 2024, before declining to ₹0.27 crore in June 2025, ₹0.67 crore in September 2025 and ₹1.32 crore in December 2025.

The company reported losses in the September and December 2025 quarters, with operating profit of negative ₹0.25 crore and negative ₹0.30 crore, respectively. Operating profit turned marginally positive at ₹0.07 crore in March 2026 before rising to ₹1.00 crore in June 2026. This sequence provides context for the sharp year-on-year percentage growth in the latest quarter.

For FY26, a reported earnings update said sales declined 75.72% to ₹4.79 crore from ₹19.73 crore in FY25. The same update reported a net loss of ₹0.48 crore for FY26, compared with a net loss of ₹1.47 crore in FY25. The annual figures underline that the June-quarter improvement follows a period of reduced business activity.

What should investors watch at the November 5 board meeting?

Shree Ganesh Elastoplast's board is scheduled to meet on November 5, 2026, to consider unaudited Q2 FY27 and first-half FY27 financial results for the quarter ended September 30, 2026. The company announced the board meeting on October 28, 2026.

The company also said its trading window would remain closed from October 1, 2026, until 48 hours after the release of the Q2 FY27 unaudited results, under its code of conduct and SEBI insider trading requirements. As of the stated meeting date, Q2 FY27 financial results had not been provided in the available information.

The key data point for investors will be whether income remains near the Q1 FY27 level of ₹4.09 crore and whether profitability can be sustained after the 24.19% net margin achieved in the June quarter. The Q1 improvement was significant relative to both the previous quarter and the year-earlier period, but the company’s recent record includes sharp changes in revenue and operating margins.

Conclusion

Shree Ganesh Elastoplast delivered a materially stronger Q1 FY27, with total income rising to ₹4.09 crore and net profit reaching ₹0.99 crore. The quarter represented an improvement from the ₹0.04 crore profit in Q4 FY26 and the ₹0.10 crore profit in Q1 FY26, while margins also recovered from the preceding quarter.

The next disclosed event is the November 5, 2026 board meeting for Q2 FY27 and first-half FY27 unaudited results. Investors will watch the reported income, expenses, operating margin and profit figures to assess whether the June-quarter performance is sustained.